Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
You asked, we listened: New resource for people with HIV on Medicare-Medicaid dual eligibility now available.News Article updated on 01/22/2024
-
Kern County Rapid ART
Kern County Rapid ART links people with a new diagnosis of HIV to ART. The Kern County Health Officer’s Clinic identifies people with a new diagnosis of HIV through onsite testing, surveillance data, and referrals from local hospital emergency departments. Kern County Rapid ART provides support services and refers clients to other community clinics for ongoing care. A study of clients with a new diagnosis of HIV in 2021 found that on average, Kern County Rapid ART clients were linked to care and provided ART within two days of diagnosis.Resource from the RWHAP Best Practices Compilation updated on 06/18/2024
-
Meet the ACE TA Center: Microlearning Module
This short hello from the ACE Team is designed to welcome and orient you to the ACE TA Center.Resource updated 10/30/2023
-
JumpstART
JumpstART launched in 2016 as part of New York State’s Ending the Epidemic initiative, changing the service delivery model of eight sexual health clinics to include an initial prescription of ART after an HIV diagnosis and prior to linkage to the community provider. Between November 2016 and September 2018, 60% of JumpstART clients received ART on the same day as diagnosis. JumpstART clients were also more likely to reach viral suppression within three months compared to non-JumpstART clients.Resource from the RWHAP Best Practices Compilation updated on 12/15/2023
-
Understanding Dual Eligibility: A Guide for People with HIV About Medicare and Medicaid Coverage
Medicare-Medicaid dual eligibility can be a complex topic with many nuances.
This tool is intended to help people with HIV understand the basics of eligibility and coverage, the unique benefits of being dually eligible for both programs, as well as how the Ryan White HIV/AIDS Program (RWHAP) can support dually eligible clients.
This tool covers:
Resource updated 01/12/2024
-
Input Sought on Federal HIV Research Priorities
The NIH Office of AIDS Research (OAR) leads the effort across NIH to establish HIV research priorities and develop the NIH Strategic Plan for HIV and HIV-Related Research.News Article updated on 02/15/2024 -
Ryan White and World AIDS Day 2022
Learn about World AIDS Day and activities of HRSA's Ryan White HIV/AIDS Program.
Blog updated 11/09/2023
-
ACE TA Center
Capacity building for the RWHAP community to navigate the changing health care landscape and help people with HIV to access and use their health coverage to improve health outcomes. Project period: 2022-2025.RWHAP Technical Assistance Provider updated on 06/24/2024
-
Creating a Jail Linkage Program: Training Manual
Lessons learned from the SPNS initiative Enhancing Linkages to HIV Primary Care & Services in Jail Settings.
Curriculum updated on 09/01/2013 -
Calculators: ACA Premiums, Subsidies and Eligibility
Online calculators are available to help individuals and families estimate the cost of health insurance coverage.
Resource updated 09/19/2023
-
Health Coverage Eligibility Decision Tree
Tool to help program staff assess whether a client may be eligible for Marketplace or Medicaid health coverage.
Resource updated 09/19/2023
-
Health Care Plan Selection Worksheet
A worksheet for program staff to use when helping clients compare and select a health insurance plan.
Resource updated 05/22/2024
-
Common Questions and Suggested Responses for Engaging Clients in Health Coverage
A guide to provide RWHAP staff with sample language to use when addressing client concerns.
Resource updated 09/19/2023
-
Guía de referencia rápida en lenguaje sencillo para inscripción en seguro de salud
Use esta guía de referencia rápida para explicar términos y frases confusas y aumentar la comprensión del cliente sobre los términos técnicos comunes usados durante el proceso de inscripción.
Resource updated 09/19/2023
-
Preguntas comunes y respuestas sugeridas para involucrar a los clientes en la cobertura de salud
Esta guía puede ayudar a los proveedores RWHAP a hablar con sus clientes sobre la nueva cobertura de salud. La guía provee ejemplos de cómo responder a las preocupaciones de los clientes sobre el acceso y posibles cambios de proveedor o cobertura. También, incluye ejemplos de respuestas que reconocen y responden a las inquietudes de los clientes que no confían en el sistema de salud, o que pueden estar preocupados por el impacto de la inscripción en el estatus migratorio de sus familiares. This guide can help RWHAP providers start talking with their clients about new health coverage.
Resource updated 09/19/2023
-
FAQ: Premium Tax Credits (PTCs) and Cost-Sharing Reductions (CSRs)
How financial subsidies (tax credits and cost-sharing reductions) can help clients pay premiums and lower the amount they have to pay out-of-pocket for deductibles, coinsurance, and co-payments.Resource updated 04/18/2024
-
Every Reasonable Effort Marketplace Participation for Uninsured Ryan White Clients
Tool and policy for RWHAP programs to document that they made “every reasonable effort” to enroll potentially eligible uninsured clients in health insurance coverage.
Resource updated 09/19/2023
-
Linking Ryan White HIV/AIDS Program Clients of Color to New Health Coverage Options: Outreach and Enrollment Challenges Faced by Grantees and Providers
Results of a needs assessment to help define training and technical assistance services for RWHAP in linking eligible clients to Affordable Care Act health coverage options.
Resource updated 09/14/2023
-
The Federal Income Tax Filing Deadline is April 15, 2024
Ryan White HIV/AIDS Program (RWHAP) clients should be sure to file their federal taxes, or request an extension, by April 15, 2024.Blog updated 03/21/2024
-
Long-Acting HIV Treatment Demonstrates Efficacy in People with Challenges Taking Daily Medicine as Prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen.News Article updated on 02/28/2024